Tower Research Capital (TRC)’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-110
| Closed | -$212 | – | 5192 |
|
|
2025
Q4 | $212 | Buy |
+110
| New | +$220 | ﹤0.01% | 4992 |
|
|
2025
Q3 | – | Sell |
-1,440
| Closed | -$3.44K | – | 5284 |
|
|
2025
Q2 | $3.44K | Sell |
1,440
-2
| -0.1% | -$6 | ﹤0.01% | 4494 |
|
|
2025
Q1 | $4.17K | Sell |
1,442
-194
| -12% | -$602 | ﹤0.01% | 4289 |
|
|
2024
Q4 | $5.1K | Buy |
1,636
+129
| +9% | +$447 | ﹤0.01% | 4350 |
|
|
2024
Q3 | $4.88K | Buy |
1,507
+232
| +18% | +$793 | ﹤0.01% | 4391 |
|
|
2024
Q2 | $5.14K | Sell |
1,275
-417
| -25% | -$2.02K | ﹤0.01% | 4713 |
|
|
2024
Q1 | $9.95K | Sell |
1,692
-435
| -20% | -$2.13K | ﹤0.01% | 3770 |
|
|
2023
Q4 | $7.89K | Buy |
2,127
+425
| +25% | +$1.94K | ﹤0.01% | 4567 |
|
|
2023
Q3 | $9.44K | Buy |
1,702
+880
| +107% | +$7.24K | ﹤0.01% | 4217 |
|
|
2023
Q2 | $8.98K | Sell |
822
-585
| -42% | -$6.95K | ﹤0.01% | 4353 |
|
|
2023
Q1 | $17K | Buy |
1,407
+143
| +11% | +$1.9K | ﹤0.01% | 3622 |
|
|
2022
Q4 | $13K | Sell |
1,264
-815
| -39% | -$9.11K | ﹤0.01% | 3591 |
|
|
2022
Q3 | $25K | Buy |
2,079
+25
| +1% | +$343 | ﹤0.01% | 3748 |
|
|
2022
Q2 | $30K | Sell |
2,054
-1,443
| -41% | -$21.7K | ﹤0.01% | 3374 |
|
|
2022
Q1 | $62K | Buy |
+3,497
| New | +$66.1K | ﹤0.01% | 2559 |
|
|
2021
Q4 | – | Sell |
-6,187
| Closed | -$124K | – | 6196 |
|
|
2021
Q3 | $124K | Buy |
6,187
+6,099
| +6,931% | +$120K | ﹤0.01% | 2210 |
|
|
2021
Q2 | $2K | Sell |
88
-112
| -56% | -$1.91K | ﹤0.01% | 5026 |
|
|
2021
Q1 | $4K | Sell |
200
-198
| -50% | -$4.83K | ﹤0.01% | 4764 |
|
|
2020
Q4 | $6K | Sell |
398
-621
| -61% | -$8.7K | ﹤0.01% | 4539 |
|
|
2020
Q3 | $12K | Sell |
1,019
-99
| -9% | -$1.32K | ﹤0.01% | 4019 |
|
|
2020
Q2 | $13K | Buy |
+1,118
| New | +$13.7K | ﹤0.01% | 3893 |
|
|
2017
Q3 | – | Sell |
-230
| Closed | -$12K | – | 3829 |
|
|
2017
Q2 | $12K | Buy |
230
+187
| +435% | +$10.9K | ﹤0.01% | 1494 |
|
|
2017
Q1 | $4K | Sell |
43
-15
| -26% | -$2.17K | ﹤0.01% | 2302 |
|
|
2016
Q4 | $5K | Buy |
58
+39
| +205% | +$3.72K | ﹤0.01% | 3026 |
|
|
2016
Q3 | $2K | Sell |
19
-4
| -17% | -$896 | ﹤0.01% | 3054 |
|
|
2016
Q2 | $6K | Buy |
23
+22
| +2,200% | +$7.04K | ﹤0.01% | 3252 |
|
|
2016
Q1 | $0 | Sell |
1
-52
| -98% | -$14.7K | ﹤0.01% | 4245 |
|
|
2015
Q4 | $18K | Buy |
+53
| New | +$22K | ﹤0.01% | 1391 |
|
|
2015
Q2 | – | Sell |
-8
| Closed | -$8K | – | 4482 |
|
|
2015
Q1 | $8K | Buy |
+8
| New | +$7.74K | ﹤0.01% | 2944 |
|
|
2014
Q3 | – | Sell |
-14
| Closed | -$10K | – | 4481 |
|
|
2014
Q2 | $10K | Buy |
+14
| New | +$10.8K | ﹤0.01% | 2352 |
|
Other funds holding DARE
VCM
VFT
XT
Tower Research Capital (TRC)'s DARE Position: Q1 2026 in Review
Tower Research Capital (TRC) sold out of Dare Bioscience (DARE) in Q1 2026, closing a stake of 110 shares — an estimated $212 sold.
Tower Research Capital (TRC) first reported a position in DARE in Q2 2014 and held it in 30 quarters. The position peaked at $124K in Q3 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.
- Tower Research Capital (TRC) reported no remaining Dare Bioscience position as of Q1 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 110 Dare Bioscience shares in Q1 2026, an estimated $212.
- Tower Research Capital (TRC) first reported a position in Dare Bioscience in Q2 2014 and held it in 30 quarters.
- Tower Research Capital (TRC)'s Dare Bioscience position peaked at $124K in Q3 2021.
- 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.